Department of Materials Science and Engineering, Kroto Research Institute, University of Sheffield, Sheffield, United Kingdom.
Invest Radiol. 2011 Nov;46(11):711-7. doi: 10.1097/RLI.0b013e31822b1f38.
Nephrogenic systemic fibrosis occurs in patients with poor renal function who receive gadolinium-based contrast agents (Gd-CAs). Several reports suggest that this is more likely to occur with the less stable forms of Gd chelates, suggesting a release of cytotoxic free Gd ions from these. There is evidence that Gd can stimulate human fibroblast proliferation but the evidence is less clear concerning the production of collagen by these cells. Our aim was to assess effects of Gd chelates on human skin cell activity and collagen production.
Keratinocytes and fibroblasts were cultured with 3 Gd chelates (Gd-EDTA, Omniscan [nonionic linear Gd-CA], and Dotarem [ionic macrocyclic Gd-CA]) for up to 7 days, and cell viability and collagen production were assessed using the colorimetric assays of MTT (3-(4, 5-dimethylthiazol-2-yl) 2, 5-diphenyltetrazolium bromide) and Sirius Red, respectively. The uptake of Gd by cultured fibroblasts was also undertaken using the techniques of inductively coupled plasma mass spectrometry and relaxometry.
Our data show that Gd-EDTA and Omniscan significantly stimulated both fibroblast and keratinocyte viability and fibroblast (but not keratinocyte) collagen production. In contrast, Dotarem had little, if any, effect on these cultured cells. The Omniscan-induced increase in fibroblast collagen was around 40% over 7 days-a similar increase to that seen for cell viability, suggesting that collagen production was secondary to an initial stimulatory effect on fibroblast viability. Studies of the uptake of Gd by the cultured fibroblasts showed that these took up Gd when cultured with Omniscan for 7 days, and our study also suggests that some of this Gd was in a free dissociated form.
We conclude that these results support a simple nephrogenic systemic fibrosis causative role of low-stability nonionic linear Gd-CA inducing dermal collagen via the release of dissociated Gd which enters fibroblasts and stimulates their activity and associated collagen production.
肾源性系统纤维化发生于肾功能不佳的患者,他们接受了基于钆的造影剂(Gd-CAs)的治疗。有几项报告表明,这种情况更有可能发生在不太稳定的 Gd 螯合物形式中,这表明这些螯合物会从细胞中释放出细胞毒性游离 Gd 离子。有证据表明 Gd 可以刺激人成纤维细胞的增殖,但关于这些细胞产生胶原蛋白的证据就不那么明确了。我们的目的是评估 Gd 螯合物对人皮肤细胞活性和胶原蛋白产生的影响。
将角质形成细胞和成纤维细胞与 3 种 Gd 螯合物(Gd-EDTA、Omniscan[非离子线性 Gd-CA]和 Dotarem[离子大环 Gd-CA])一起培养长达 7 天,并使用 MTT(3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四唑溴化物)比色法和 Sirius Red 分别评估细胞活力和胶原蛋白产生。还使用电感耦合等离子体质谱和弛豫测量技术研究了培养的成纤维细胞对 Gd 的摄取。
我们的数据表明,Gd-EDTA 和 Omniscan 显著刺激了成纤维细胞和角质形成细胞的活力以及成纤维细胞(但不是角质形成细胞)的胶原蛋白产生。相比之下,Dotarem 对这些培养细胞几乎没有影响。Omniscan 诱导的成纤维细胞胶原蛋白增加约 40%,持续 7 天-与细胞活力的增加相似,这表明胶原蛋白的产生是成纤维细胞活力初始刺激作用的结果。对培养的成纤维细胞摄取 Gd 的研究表明,当用 Omniscan 培养 7 天时,这些细胞摄取了 Gd,我们的研究还表明,其中一些 Gd 处于游离的游离形式。
我们得出的结论是,这些结果支持了一种简单的肾源性系统纤维化病因假说,即低稳定性非离子线性 Gd-CA 通过释放进入成纤维细胞并刺激其活性和相关胶原蛋白产生的游离 Gd 诱导真皮胶原蛋白。